| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 3 securities · may seek to influence control | ||||||
|
ENvue Medical, Inc.
13D/A
29416M103
|
0% |
6/22/2026
Event 6/22/2026
|
||||
|
ENvue Medical, Inc.
13D/A
FEED · 63008J884
|
6.5% |
4/17/2026
Event 1/14/2026
|
||||
|
ENvue Medical, Inc.
13D
29415F100
|
22.0% |
2/11/2026
Event 1/14/2026
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.